The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
89bio Inc | EQUITIES | 282559103 | 1,772,891 | 158,719 | SH | SOLE | 158,719 | 0 | 0 | ||
Akero Therapeutics Inc | EQUITIES | 00973Y108 | 5,820,081 | 249,254 | SH | SOLE | 249,254 | 0 | 0 | ||
Aligos Therapeutics Inc | EQUITIES | 01626L105 | 443,892 | 668,512 | SH | SOLE | 668,512 | 0 | 0 | ||
Alpine Immune Sciences Inc | EQUITIES | 02083G100 | 5,675,858 | 297,789 | SH | SOLE | 297,789 | 0 | 0 | ||
Altimmune Inc | EQUITIES | 02155H200 | 1,687,500 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
Annexon Inc | EQUITIES | 03589W102 | 1,895,128 | 417,429 | SH | SOLE | 417,429 | 0 | 0 | ||
Apellis Pharmaceuticals Inc | EQUITIES | 03753U106 | 598,600 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | ||
BioCryst Pharmaceuticals Inc | EQUITIES | 09058V103 | 1,489,881 | 248,728 | SH | SOLE | 248,728 | 0 | 0 | ||
Biogen Idec Inc | EQUITIES | 09062X103 | 5,175,400 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
Biohaven Ltd | EQUITIES | G1110E107 | 3,025,746 | 70,695 | SH | SOLE | 70,695 | 0 | 0 | ||
Caribou Biosciences Inc | EQUITIES | 142038108 | 5,161,687 | 900,818 | SH | SOLE | 900,818 | 0 | 0 | ||
Celldex Therapeutics Inc | EQUITIES | 15117B202 | 9,804,547 | 247,215 | SH | SOLE | 247,215 | 0 | 0 | ||
Cerus Corp | EQUITIES | 157085101 | 3,239,678 | 1,499,851 | SH | SOLE | 1,499,851 | 0 | 0 | ||
Cogent Biosciences Inc | EQUITIES | 19240Q201 | 5,684,478 | 966,748 | SH | SOLE | 966,748 | 0 | 0 | ||
Compugen Ltd | EQUITIES | M25722105 | 1,861,200 | 940,000 | SH | SOLE | 940,000 | 0 | 0 | ||
CymaBay Therapeutics Inc | EQUITIES | 23257D103 | 5,172,190 | 218,975 | SH | SOLE | 218,975 | 0 | 0 | ||
DexCom Inc | EQUITIES | 252131107 | 3,846,790 | 31,000 | SH | SOLE | 31,000 | 0 | 0 | ||
Evogene Ltd | EQUITIES | M4119S104 | 2,604,000 | 3,100,000 | SH | SOLE | 3,100,000 | 0 | 0 | ||
Gossamer Bio Inc | EQUITIES | 38341P102 | 5,593,870 | 6,130,268 | SH | SOLE | 6,130,268 | 0 | 0 | ||
Immunovant Inc | EQUITIES | 45258J102 | 842,600 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
Insmed Inc | EQUITIES | 457669307 | 4,819,069 | 155,504 | SH | SOLE | 155,504 | 0 | 0 | ||
Intellia Therapeutics Inc | EQUITIES | 45826J105 | 1,671,523 | 54,822 | SH | SOLE | 54,822 | 0 | 0 | ||
Intra-Cellular Therapies Inc | EQUITIES | 46116X101 | 5,729,600 | 80,000 | SH | SOLE | 80,000 | 0 | 0 | ||
Intuitive Surgical Inc | EQUITIES | 46120E602 | 5,332,987 | 15,808 | SH | SOLE | 15,808 | 0 | 0 | ||
KalVista Pharmaceuticals Inc | LONG OPTION CALLS | 483497103 | 2,209,900 | 180,400 | SH | Call | SOLE | 180,400 | 0 | 0 | |
KalVista Pharmaceuticals Inc | EQUITIES | 483497103 | 1,368,742 | 111,734 | SH | SOLE | 111,734 | 0 | 0 | ||
Karyopharm Therapeutics Inc | EQUITIES | 48576U106 | 486,091 | 561,955 | SH | SOLE | 561,955 | 0 | 0 | ||
Kodiak Sciences Inc | EQUITIES | 50015M109 | 3,040,000 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
MacroGenics Inc | EQUITIES | 556099109 | 12,108,126 | 1,258,641 | SH | SOLE | 1,258,641 | 0 | 0 | ||
Medtronic PLC | EQUITIES | G5960L103 | 11,121,300 | 135,000 | SH | SOLE | 135,000 | 0 | 0 | ||
Mersana Therapeutics Inc | LONG OPTION CALLS | 59045L106 | 699,712 | 301,600 | SH | Call | SOLE | 301,600 | 0 | 0 | |
Mersana Therapeutics Inc | EQUITIES | 59045L106 | 14,894,716 | 6,420,136 | SH | SOLE | 6,420,136 | 0 | 0 | ||
Merus NV | EQUITIES | N5749R100 | 17,753,478 | 645,581 | SH | SOLE | 645,581 | 0 | 0 | ||
Mirati Therapeutics Inc | LONG OPTION CALLS | 60468T105 | 8,812,500 | 150,000 | SH | Call | SOLE | 150,000 | 0 | 0 | |
Mirum Pharmaceuticals Inc | EQUITIES | 604749101 | 2,385,541 | 80,811 | SH | SOLE | 80,811 | 0 | 0 | ||
Molecular Templates Inc | EQUITIES | 608550208 | 1,322,688 | 354,608 | SH | SOLE | 354,608 | 0 | 0 | ||
MoonLake Immunotherapeutics | EQUITIES | 61559X104 | 3,019,500 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
Morphic Holding Inc | EQUITIES | 61775R105 | 14,441,213 | 500,042 | SH | SOLE | 500,042 | 0 | 0 | ||
Nuvalent Inc | EQUITIES | 670703107 | 14,202,870 | 193,000 | SH | SOLE | 193,000 | 0 | 0 | ||
Olema Pharmaceuticals Inc | EQUITIES | 68062P106 | 8,050,835 | 573,830 | SH | SOLE | 573,830 | 0 | 0 | ||
Oric Pharmaceuticals Inc | EQUITIES | 68622P109 | 10,764,000 | 1,170,000 | SH | SOLE | 1,170,000 | 0 | 0 | ||
Penumbra Inc | EQUITIES | 70975L107 | 5,030,800 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
Pliant Therapeutics Inc | EQUITIES | 729139105 | 5,768,470 | 318,524 | SH | SOLE | 318,524 | 0 | 0 | ||
Pmv Pharmaceuticals Inc | EQUITIES | 69353Y103 | 1,705,000 | 550,000 | SH | SOLE | 550,000 | 0 | 0 | ||
Poseida Therapeutics Inc | EQUITIES | 73730P108 | 12,451,417 | 3,705,779 | SH | SOLE | 3,705,779 | 0 | 0 | ||
Praxis Precision Medicines Inc | EQUITIES | 74006W207 | 6,323,977 | 283,841 | SH | SOLE | 283,841 | 0 | 0 | ||
Relmada Therapeutics Inc | EQUITIES | 75955J402 | 414,000 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
Rezolute Inc | EQUITIES | 76200L309 | 155,907 | 157,085 | SH | SOLE | 157,085 | 0 | 0 | ||
Rhythm Pharmaceuticals Inc | EQUITIES | 76243J105 | 8,010,181 | 174,248 | SH | SOLE | 174,248 | 0 | 0 | ||
Rocket Pharmaceuticals Inc | EQUITIES | 77313F106 | 11,468,680 | 382,672 | SH | SOLE | 382,672 | 0 | 0 | ||
Rocket Pharmaceuticals Inc Wts | WARRANTS | 77313F114 | 51,366 | 104,828 | SH | SOLE | 104,828 | 0 | 0 | ||
Sanofi SA | EQUITIES | 80105N105 | 10,940,600 | 220,000 | SH | SOLE | 220,000 | 0 | 0 | ||
Sarepta Therapeutics Inc | EQUITIES | 803607100 | 4,521,024 | 46,884 | SH | SOLE | 46,884 | 0 | 0 | ||
Scholar Rock Holding Corp | EQUITIES | 80706P103 | 5,076,000 | 270,000 | SH | SOLE | 270,000 | 0 | 0 | ||
Schrodinger Inc | EQUITIES | 80810D103 | 1,113,989 | 31,117 | SH | SOLE | 31,117 | 0 | 0 | ||
Soleno Therapeutics Inc | EQUITIES | 834203309 | 2,965,016 | 73,665 | SH | SOLE | 73,665 | 0 | 0 | ||
Solid Biosciences Inc | EQUITIES | 83422E204 | 3,652,410 | 594,855 | SH | SOLE | 594,855 | 0 | 0 | ||
Tela Bio Inc | EQUITIES | 872381108 | 5,263,430 | 795,080 | SH | SOLE | 795,080 | 0 | 0 | ||
Terns Pharmaceuticals Inc | EQUITIES | 880881107 | 3,355,324 | 516,999 | SH | SOLE | 516,999 | 0 | 0 | ||
Trevi Therapeutics Inc | EQUITIES | 89532M101 | 1,157,603 | 863,883 | SH | SOLE | 863,883 | 0 | 0 | ||
United Therapeutics Corp | EQUITIES | 91307C102 | 3,597,400 | 16,360 | SH | SOLE | 16,360 | 0 | 0 | ||
Urogen Pharma Ltd | EQUITIES | M96088105 | 7,881,060 | 525,404 | SH | SOLE | 525,404 | 0 | 0 | ||
Veracyte Inc | EQUITIES | 92337F107 | 6,814,860 | 247,723 | SH | SOLE | 247,723 | 0 | 0 | ||
Viridian Therapeutics Inc | EQUITIES | 92790C104 | 1,098,540 | 50,438 | SH | SOLE | 50,438 | 0 | 0 | ||
Xenon Pharmaceuticals Inc | EQUITIES | 98420N105 | 7,515,518 | 163,168 | SH | SOLE | 163,168 | 0 | 0 | ||
Zura Bio Ltd | EQUITIES | G9TY5A101 | 2,162,196 | 462,997 | SH | SOLE | 462,997 | 0 | 0 | ||
argenx SE | EQUITIES | 04016X101 | 1,835,955 | 4,826 | SH | SOLE | 4,826 | 0 | 0 |